[1]
Arifianto, H. et al. 2026. Emerging therapeutic strategies for obesity management for cardiovascular risk reduction in resource-limited settings: A review focusing on semaglutide. Narra X. 4, 3 (Nov. 2026), e381. DOI:https://doi.org/10.52225/narrax.v4i3.381.